Mah Sing launches Mah Sing DC Hub@ Southville City with Bridge Data Centres
KUALA LUMPUR, Malaysia, May 30, 2024 /PRNewswire/ — Bursa Malaysia listed developer Mah Sing Group Berhad (MAHS.KL 8583) has made a significant leap into the data centre sector with the launch of Mah Sing DC Hub@Southville City. The project’s first partner is Bridge Data Centres (BDC),
The St. Regis Sanya Yalong Bay Resort Elevates Exclusive Services for Russian Tourists
SANYA, China, May 30, 2024 /PRNewswire/ — As China further expands visa-free entry policies, the number of inbound tours to Sanya continues to climb. The city, as a popular seaside vacation destination, is attracting a large number of Russian tourists. Nestled in the idyllic and charming Yalon
ChipMOS to PRESENT at CITI’S 2024 TAIWAN TECH CONFERENCE
HSINCHU, May 30, 2024 /PRNewswire-FirstCall/ — ChipMOS TECHNOLOGIES INC. (“ChipMOS” or the “Company”) (Taiwan Stock Exchange: 8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services (“OSAT”), today announc
Zhihu Inc. to Hold Annual General Meeting on June 26, 2024
BEIJING, May 30, 2024 /PRNewswire/ — Zhihu Inc. (NYSE: ZH; HKEX: 2390) (“Zhihu” or the “Company”), a leading online content community in China, today announced that it will hold an annual general meeting of the Company’s shareholders (the “AGM”) at 10:
Patoranking Foundation and ALX Africa Unveil a $500,000 Scholarship Initiative for Tech-Savvy African Youth
LAGOS, Nigeria, May 30, 2024 /PRNewswire/ — Founded by African musician Patoranking, the Patoranking Foundation, a beacon of hope for young African talent, is pleased to announce the launch of the Patoranking Foundation Tech Scholarships, a key part of the organization’s Sky Level Initi
InxMed Reports Positive Phase Ib/II Results for Ifebemtinib in Combination with Garsorasib in Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation
Ifebemtinib in combination with garsorasib in NSCLC showed ORR of 90.3% and DCR of 96.8% Ifebemtinib is a highly selective, orally administered, focal adhesion kinase inhibitor with significant synergies with a broad spectrum of therapeutic modalities NANJING, China, May 30, 2024 /PRNewswire/ —
Canadian medical organizations call on federal government to exempt physicians from increase to capital gains inclusion rate
OTTAWA, ON, May 30, 2024 /CNW/ – National, provincial and territorial medical associations are calling on the federal government to exempt medical professional corporations from a planned increase to the capital gains inclusion rate. “The proposed changes to increase the capital gains in
Kexing Biopharm Obtained Clinical Trial Approval for its Self-developed Class I Innovative Drug–Long-acting Growth Hormone
SHENZHEN, China, May 30, 2024 /PRNewswire/ — On the 24th of May, Kexing Biopharm (688136.SH) announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clinical Trials from the National Medical Products Administration,
INCUBASE Arena to Host Extended Fullmetal Alchemist Exhibition Until July 1st
HONG KONG, May 30, 2024 /PRNewswire/ — Incubase Studio is excited to announce that the Fullmetal Alchemist Exhibition at the new INCUBASE Arena in Hong Kong will now be extended until July 1st, providing an even greater opportunity for anime fans to experience this enthralling showcase. The ex
Trip.com Group Outlines Future Growth Strategies at Envision 2024 Global Partner Conference
SHANGHAI, May 30, 2024 /PRNewswire/ — Trip.com Group set the stage for transformative growth at the Envision 2024 Global Partner Conference, sharing its strategic vision with over 1,600 partners from more than 50 countries and regions. The conference, focused on the forward-looking theme of &#
